ARCHIVES

Drug Effectiveness Weakens After Three Years, Study Says

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

DePinho’s Letter to the AAUP

May 30, 2014

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

NIH To Sponsor Animal Care, Human Protection Workshop

February 21, 1986

Michael Link Elected ASCO President.

January 15, 2010

Kidney Cancer Group Seeks Proposals; AACR Offers Award

November 17, 1995